Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.03%21.2B | -8.12%46.45B | -6.95%22.8B | 0.87%50.56B | -1.19%24.5B | 8.15%50.12B | 10.79%24.8B | 31.91%46.35B | 43.18%22.39B | -1.06%35.13B |
| Operating income | -7.03%21.2B | -8.12%46.45B | -6.95%22.8B | 0.87%50.56B | -1.19%24.5B | 8.15%50.12B | 10.79%24.8B | 31.91%46.35B | 43.18%22.39B | -1.06%35.13B |
| Cost of sales | 7.37%-20.64B | 7.80%-45.77B | 7.30%-22.29B | -0.86%-49.64B | 0.25%-24.04B | -10.55%-49.21B | -13.89%-24.1B | -32.10%-44.52B | -40.75%-21.16B | 2.08%-33.7B |
| Operating expenses | 7.37%-20.64B | 7.80%-45.77B | 7.30%-22.29B | -0.86%-49.64B | 0.25%-24.04B | -10.55%-49.21B | -13.89%-24.1B | -32.10%-44.52B | -40.75%-21.16B | 2.08%-33.7B |
| Gross profit | 7.62%553.7M | -25.59%685.69M | 10.82%514.47M | 1.42%921.53M | -33.76%464.23M | -50.27%908.63M | -42.80%700.88M | 27.44%1.83B | 104.17%1.23B | 31.31%1.43B |
| Selling expenses | -2.24%-233.43M | -2.66%-506.39M | -1.28%-228.3M | -1.74%-493.26M | 2.61%-225.42M | -3.81%-484.85M | 12.42%-231.46M | -22.22%-467.06M | -56.50%-264.28M | -8.52%-382.16M |
| Administrative expenses | -4.67%-184.6M | 3.92%-437.7M | -25.48%-176.37M | -2.79%-455.54M | 19.80%-140.56M | -1.94%-443.15M | 29.20%-175.25M | -15.82%-434.71M | -62.98%-247.54M | -24.74%-375.32M |
| Special items of operating profit | -68.57%8.36M | 8.60%61.72M | -32.50%26.59M | -2.52%56.83M | 489.92%39.39M | 62.87%58.3M | -50.73%6.68M | 6.95%35.8M | 8.45%13.55M | -30.85%33.47M |
| Operating profit | 5.60%144.02M | -765.31%-196.69M | -0.91%136.39M | -24.07%29.56M | -54.25%137.65M | -95.95%38.93M | -58.62%300.85M | 35.43%961.23M | 149.10%726.96M | 45.66%709.79M |
| Financing income | 23.97%26.7M | 22.76%44.84M | -33.34%21.54M | -17.95%36.53M | 21.19%32.3M | 27.96%44.52M | 46.73%26.66M | 10.01%34.79M | 23.99%18.17M | 21.47%31.63M |
| Financing cost | 4.65%-137.15M | -4.49%-286.68M | 5.13%-143.83M | 1.25%-274.37M | -40.16%-151.62M | -4.11%-277.85M | 16.64%-108.17M | -23.88%-266.89M | -16.21%-129.76M | 5.74%-215.43M |
| Earning before tax | 138.22%33.57M | -110.55%-438.53M | -23.14%14.09M | -7.14%-208.28M | -91.64%18.33M | -126.66%-194.4M | -64.36%219.34M | 38.63%729.14M | 215.84%615.37M | 84.70%525.98M |
| Tax | -131.41%-10.8M | 200.12%53.39M | 30.41%-4.67M | -49.98%17.79M | 88.98%-6.71M | 117.64%35.56M | 58.63%-60.85M | -43.81%-201.57M | -170.76%-147.11M | -57.14%-140.17M |
| After-tax profit from continuing operations | 141.59%22.77M | -102.18%-385.14M | -18.95%9.42M | -19.93%-190.49M | -92.66%11.63M | -130.11%-158.83M | -66.15%158.49M | 36.74%527.57M | 233.27%468.26M | 97.27%385.81M |
| Earning after tax | 141.59%22.77M | -102.18%-385.14M | -18.95%9.42M | -19.93%-190.49M | -92.66%11.63M | -130.11%-158.83M | -66.15%158.49M | 36.74%527.57M | 233.27%468.26M | 97.27%385.81M |
| Minority profit | 204.49%15.19M | 3.03%29.44M | 15.87%4.99M | 46.77%28.58M | -54.07%4.31M | -40.14%19.47M | -33.29%9.37M | -14.03%32.52M | 9.15%14.05M | 109.74%37.83M |
| Profit attributable to shareholders | 70.85%7.58M | -89.25%-414.58M | -39.42%4.44M | -22.86%-219.07M | -95.09%7.32M | -136.02%-178.3M | -67.17%149.11M | 42.26%495.04M | 255.87%454.22M | 96.00%347.98M |
| Basic earnings per share | 68.57%0.0059 | -94.12%-0.33 | -38.60%0.0035 | -21.43%-0.17 | -95.25%0.0057 | -135.00%-0.14 | -66.67%0.12 | 42.86%0.4 | 260.00%0.36 | 100.00%0.28 |
| Diluted earnings per share | 68.57%0.0059 | -94.12%-0.33 | -38.60%0.0035 | -21.43%-0.17 | -95.25%0.0057 | -135.00%-0.14 | -66.67%0.12 | 42.86%0.4 | 260.00%0.36 | 100.00%0.28 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.